25.04.2024 08:20:57 - dpa-AFX: *HIKMA PHARMA STILL EXPECTS FY CORE OPERATING PROFIT TO BE $660 MLN TO $700 MLN

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
HIKMA PHARMACEUTIC.LS-,10 A0HG69 Frankfurt 22,000 02.07.24 21:49:52 -0,200 -0,90% 0,000 0,000 21,600 22,200

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH